1 / 50

Growth Factors and Receptor Tyrosine Kinases

Growth Factors and Receptor Tyrosine Kinases. RTK’s--How do they work? EGFR signaling and ras MAP k inase cascades PI3K, PKB, PLC g PTPs (Protein Tyrosine Phosphatases). Epidermal growth factor. Neurotrophic growth factor (NGF) isolated from mouse

saxton
Download Presentation

Growth Factors and Receptor Tyrosine Kinases

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Growth Factors and Receptor Tyrosine Kinases • RTK’s--How do they work? • EGFR signaling and ras • MAP kinase cascades • PI3K, PKB, PLCg • PTPs (Protein Tyrosine Phosphatases)

  2. Epidermal growth factor Neurotrophic growth factor (NGF) isolated from mouse submaxillary glands (Rita Levi-Montalcini) Stanley Cohen, 1962 “Side effects” of impure NGF preps Premature eyelid opening (7d vs. 14 d) Premature tooth eruption (6 d vs. 9 d) Pure “Tooth-lid factor” = EGF Important roles in development no EGF EGF 1 g/kg m Mitogenic for fibroblasts Regulates growth/differentiation of many target cells Refs: S. Cohen, JBC 237:1555, 1962 S. Cohen, Nobel lecture, 1986

  3. A A A P P B Y~P provides long-lasting but erasable memory, which is terminated by DE-phosphorylation *Y = one-letter code for tyrosine; S = ser, T = thr, etc. Phospho-tyrosine signals Kinases phosphorylate tyrosine (Y*) residues of target proteins Y~P = target for distinctive protein binding pockets, with surrounding sequences lending specificity ALWAYS activate by promoting proximity of proteins A and B (sometimes by allostery also) In its new proximity to A, B’s activity (= X) can now: TK X X X Phosphorylate or de-phosphorylate another protein Make or degrade a 2nd messenger Attract additional signaling molecules B

  4. Phospho-tyrosine signals regulate growth & differentiation RTKs = Receptor Tyrosine Kinases Extracellular region variable, with many different motifs Usually cross membrane only once Intracellular region contains conserved catalytic domains Alberts, 15-47 ALSO: TK-linked receptors for: Antigens (receptors on B and T cells Growth hormone Interleukin-4 Erythropoietin, many others

  5. How RTKs (& TK-linked Rs) work 1. Ligand promotes formation of RTK dimers, by different mechanisms: Ligand itself is a dimer (PDGF) One ligand binds both monomers (GH) 2. Dimerization allows trans-phosphorylation of catalytic domains, which induces activation of catalytic (Y-kinase) activity 3. Activated TK domains phosphorylate each other and proteins nearby, sometimes on multiple tyrosines 4. Y~P residues recruit other signaling proteins, generate multiple signals EGF receptor as a model 1st RTK to be characterized v-erbB oncogene = truncated EGFR

  6. Evidence for EGFR dimerization Yarden & Schlessinger Rate of phosphorylation = k[EGFR]2, even in micelles! Therefore: 2 EGFRs required for phosphorylation Later confirmed by Chemical cross-linking FRET Dominant-negative mutants (e.g., kinase-dead EGFR) IMPORTANT Dimerization/proximity = alternative to allostery (Shown by swapping EC/IC domains of EGFR, PDGFR)

  7. wt + + + kin- + short kin- + + short kin+ How do we know that the EGFR auto- phosphorylates in trans? Experiment: test WT and short EGFRs, each with or without a kin- mutation Honneger et al. (in vitro) PNAS 1989; (in vivo) MCB 1999 Does this result rule out phosphorylation in cis as well? If not, how can you find out? PS: What do trans and cis mean?

  8. How can we know that the EGFR does not autophosphorylate in cis? Need an EGFR that cannot homodimerize EGFR family is huge, with many RTK members and many EGF-like ligands Such receptors often form obligatory heterodimers with a similar but different partner If A can dimerize only with A’, then we can inactivate the kinase domain of A’ and ask whether A phosphorylates itself Answer: NO QED

  9. Cat. loop T-loop Y1162 flips out Substrate Y sits in active site Y1162 occupies the active site How does dimerization activate RTKs? GFRs (like many kinases) have sites in their T loops at which phosphorylation activates Dimerization induces T-loop phosphorylation in trans Phosphorylation of Y (one or more) in T-loop causes it to move out of the way of the active site. Proximity by itself is usually enough to promote T-loop phosphorylation, but there may also be a role for allostery Once activated, each monomer can phosphorylate nearby Y residues in the other, as well as in other proteins

  10. Growth Factors and Receptor Tyrosine Kinases • RTK’s--How do they work? • EGFR signaling and ras • MAP Kinase Cascades • PI3K, PKB, PLCg • PTPs (Protein Tyrosine Phosphatases)

  11. . . . P . P P P P P P P P Signals generated by the EGFR The activated dimer phosphorylates itself Individual Y~P residues recruit specific proteins, generate different signals T-loop only Multiple sites SOS, a Ras GEF Docks via intermediate adapters to activate Ras Ras activates multiple targets (MAPK) PLC-g Docking of Y-kinases allows Tyr-phos’n of PLC-g, which activates it PI3-kinase Adapters again Docking allosterically activates PI3K Each signal, in turn, activates a different set of pathways, which cooperate to produce the overall response

  12. P Adapters connect A with B, B with C . . . to create complex, localized assemblies of signaling proteins Adapter 2 Each adapter has at least 2 interaction domains, and may have other functions as well C B A Types of adapter interactions Adapter 1 Y~P sequence motifs allow regulatable adapter functions SH2 Tyrosine phosphates PTB Tyrosine phosphates Also SH3 Polyproline-containing sequences PDZ Specific 4-residue sequences at C-termini Pleckstrin homol. (PH) Phosphoinositides Many others

  13. SH2 & SH3 domains--src homology domains SH domains are protein domains initially discovered in Src, a transforming tyrosine kinase found in Rous sarcoma virus. Sequences of many signaling proteins that interact with RTKs revealed multiple homologous domains to Src region 2 and region 3. SH2: Protein motif of ~100 amino acids, binds to phosphotyrosine peptide sequences. (87 SH2 in the human genome) SH3: ~60 amino acid domain, binds to R-X-X-P-X-X-P peptide sequences. (143 SH3 in the human genome) Lodish, 24-17 How would you determine the specificity of an individual SH2 domain for a phosphopeptide?

  14. EGF activates the MAPK pathway in multiple steps, with multiple mechanisms EGF Extracellular GF EGFR RTK EGFR~P Phospho-RTK Grb2 Adapter SOS Ras-GEF Ras Small GTPase Raf Ser kinase Mechanism Mek Tyr/thr kinase Proximity ERKs Ser kinase Allostery C-Jun Transcription factor Covalent modification

  15. Fly genetics to the rescue Fly eye consists of ~800 ommatidia, an individual lens structure consisting of 22 cells (8 photoreceptor cells, R1-R8) Eye development is highly ordered process. RTK signaling is essential. Mutation in sevenless results in loss of R7. Additional mutations in pathway identified sos (son-of-sevenless), boss (bride of sevenless), Drk (downstream of receptor kinase) Alberts, 15-53

  16. . P P P Ras GDP EGFR Activation of Ras: Proximity & Allostery The Players RTK = EGFR . P “Rat Sarcoma” Small GTPase, attached to PM by prenyl group P P “GF receptor binding 2” Adapter, found in screen for binders to EGFR~P “Son of Sevenless” GEF, converts Ras-GDP to Ras-GTP Found in Drosophila, homol. To S.c. Cdc25 SH3 Grb2 SH2 SOS SH3

  17. Ras GDP EGFR Activation of Ras: Proximity & Allostery Even before EGF arrives . . . . . SOS is “ready to go”: already (mostly) associated with Grb2 in cytoplasm, in the resting state SH3 SOS Grb2 SH2 SH3

  18. . P P P . P P P Ras GDP EGFR Activation of Ras: Proximity & Allostery Then . . . Covalent modification EGF-bound dimers trigger phosphorylation, in trans SH3 SOS Grb2 SH2 SH3

  19. . P P P SH3 Grb2 SH2 SH3 Ras GDP EGFR Activation of Ras: Proximity & Allostery Then . . . Proximity . P P SOS P Grb2’s SH2 domain binds Y~P on EGFR, bringing SOS to the plasma membrane

  20. . P P P SH3 SOS Grb2 SH2 SH3 Ras GDP EGFR Activation of Ras: Proximity & Allostery Then . . . Allostery . P P P GDP SOS now binds Ras-GDP, causing GDP to dissociate, and . . .

  21. . P P P SH3 Grb2 SH2 SH3 EGFR Activation of Ras: Proximity & Allostery Then . . . Allostery continues . P Ras P GTP SOS P GTP GTP enters empty pocket on Ras, which dissociates from SOS and converts into its active conformation

  22. . P P P SH3 Grb2 SH2 SH3 EGFR Activation of Ras: Proximity & Allostery Finally . . . Proximity again! . Raf P Ras P GTP SOS P GTP Raf Ras-GTP brings Raf to the PM for activation, and the MAPK cascade is initiated MAPK Cascade

  23. Ras Ras Ras Ras GTP GTP GTP GTP How does Ras activate Raf? Proximity vs. allostery? Allostery: Ras recruits Raf to the PM and activates it directly Raf* Raf MAPK Cascade (Cytoplasmic) Proximity:Ras recruits Raf to the PM, where it is activated by X X Raf* Raf MAPK Cascade (Cytoplasmic)

  24. How can we tell the difference? Does Raf signal (without Ras) when recruited to the PM? Stokoe et al. (1994) Science Experiment EXV Raf Attach a CAAX* box to Raf’s C- terminus Raf+RasG12 RafCAAX RafCAAX+Ras17N RafCAAX+RasG12V Express Raf-CAAx in cells, measure activity of MEK, an enzyme downstream in the MAPK pathway 0 10 20 Relative MEK activity *CAAX (A = aliphatic; C = cysteine) is a site for prenylation; prenylated proteins concentrate at the PM Answer: “proximity +” Ras does localize Raf but does not activate it (other proteins do)

  25. Growth Factors and Receptor Tyrosine Kinases • RTK’s--How do they work? • EGFR signaling and ras • MAP Kinase Cascades • PI3K, PKB, PLCg • PTPs (Protein Tyrosine Phosphatases)

  26. Mammalian MAP Kinase Cascades Borrowed from Chan, STKE Johnson & Lapadat (2002) Science 298: 1911

  27. . . Raf-1 P P P P A-raf B-raf MEK1 MEK2 ERK1 ERK2 The best understood MAPK cascade MAPK = Mitogen-activated protein kinase . Phos’n of T-loop Ser residues Phos’n of T-loop Thr and Tyr MAPKKK Phos’n of Ser/Thr MAPKK C-Jun MAPK Altered gene expression

  28. MAPKKK MAPKKK MAPKKK MAPKK MAPKK MAPKK MAPK MAPK MAPK MAPK “cassettes” mediate many different responses Frog oocyte Vertebrates S. cerevisiae Mitogens Progesterone Mating pheromone Cell cycle arrest, mating Proliferation G2-M transition Additional sites for regulation Different biology, similar cassettes: why 3 kinases? Combinatorial diversity Magnitude amplification Switch-like responses

  29. Frog oocyte 1.0 Progesterone Response 0.5 MAPKKK 0 0 1 5 MAPKK Stimulus (multiples of EC50) MAPK G2-M transition Switch-like behavior* Responses are not always graded Instead . . . Amplified sensitivity: reduces noise @ low stimulus; reversible Bistable responses: off or on, often via positive feedback & used for irreversible responses (e.g., cell cycle) Other examples? *JE Ferrell, Tr Bioch Sci 22:288, 1997

  30. All or nothing response in Xenopus oocytes Progesterone, or fertilization, induces germinal vesicle breakdown of Xenopus oocytes--a process mediated by the MAPK cascade. Question: At a concentration of progesterone that half-maximally activates MAPK (0.01 uM, panel A), are all the oocytes activated halfway (panel B), or are half of the oocytes activated fully (panel C)? Since Xenopus oocytes are HUGE, one can look at MAPK on a cell by cell basis. Answer: All or nothing. Ferrell, et al., Science (1998)

  31. Of course, life is not so simple . . . BONUS slide Does this work in mammalian cells? Blenis and co-workers used FACS and immunohistochemistry (anti-DP ERK Ab) to look at EGF activation of ERK in Swiss 3T3 fibroblasts MacKeigan MCB 2005

  32. Scaffolds for MAP Kinase signaling Deletion analysis of the binding of JIP-1 to JNK1, MKK7, MLK3, and DLK. JIP-1 was expressed in cells as a GST fusion protein together with HPK1 or epitope-tagged JNK1, MKK7, MLK3, and DLK (15, 16). The presence of these kinases in glutathione-agarose precipitates was examined by protein immunoblot analysis. HPK=hematopoeitic progenitor kinase DLK=dual lineage kinase (member of the MLK family) Whitmarsh et. al. (1998) Science 281: 1671

  33. Scaffolding roles of JNK-interacting proteins Dhanasekaran (2007) Oncogene

  34. Scaffold proteins involved in ERK-signaling pathways Dhanasekaran (2007) Oncogene

  35. Growth Factors and Receptor Tyrosine Kinases • RTK’s--How do they work? • EGFR signaling and ras • MAP Kinase Cascades • PI3K, PKB, PLCg • PTPs (Protein Tyrosine Phosphatases

  36. p110 p110 p85 SH2 SH2 EGFR Activation of PI3K combines Proximity & Allostery PIP2 PIP3 . . P P P P Activated by EGFR/p85 SH2 Recruitment from cytoplasm to PM, via SH2 domains p85 Can also be activated by Rac or Ras! SH2 How do we know proximity is not enough? 1. p85 mutants that activate without binding to RTKs 2. Tethering to membrane does not activate

  37. PI3-K pathway and Cancer Syndromes RTK GF Cancer Syndromes PIP3 p PI3-K Lipid Kinase GI, Brain, Ovarian PTEN Lipid PTPase Cowden’s, Multiple Akt1/2 Ser/Thr Kinase Pancreas Hamartin Tuberin (Tuberous Sclerosis Complex) TSC2 Ras GAP TSC TSC1 (Ras-homology enriched in brain) Small GTPase RheB (Target of rapamycin) mTOR Kinase S6K 4EBP-1 Kinase Inhibitor of eIF4E Protein synthesis Kovich & Cohen (2004) Dematology Online Journal 10: 3. Perelman (2004) Dematology Online Journal 10: 17. Cell growth/size/survival

  38. PH K P P P P PIP3 targetsinclude many GEFs, many tyrosine kinases, and others, including . . . PKB (aka Akt)= ser/thr kinase that promotes cell survival PIP3 (= membrane lipid) PKB . . . is inactive in cytoplasm . . . contains a PH (pleckstrin homology) domain & a kinase domain

  39. PH PH K K P P P P Multi-step activation of PKB: proximity PIP3 PH domain recognizes 3’- phosphate of PIP3, bringing kinase domain to the PM Proximity to PM alone does not activate the kinase

  40. PH PH K K P P P P P P P P P P Multi-step activation of PKB: covalent modification PDK1* PIP3 Inactive PKB Active (phos’d) PKB *PDK1 is also recruited to the membrane via a PIP3-binding PH domain Overall, two proximity steps plus (at least) one phosphorylation step

  41. Cata- lytic P P P P PH EGFR Activation of PLCg combines THREE inputs PIP2 . . PIP3 P P P PLCg (Inactive, in cytoplasm) P P P SH2 1. PROXIMITY: Recruitment from cytoplasm to PM, via SH2 domains SH2

  42. P P P P P EGFR Activation of PLCg combines THREE inputs 3. PROXIMITY: Binds to PIP3 via PH domain PIP2 DAG . . PH P P P SH2 InsP3 P P P SH2 Cata- lytic 2. COVALENT: Activated by EGFR phosph’n

  43. Summary: Many RTK effectors require two or more simultaneous inputs for activation PI3K: recruitment via SH2, allosteric regulation by EGFR,p85 PKB: recruitment, phos’n by non-EGFR-kinase(s) PLCg: recruitment, phos’n, retention at PM by binding PIP3 Why multiple inputs to each effector?

  44. RTKs activate a complex network of interacting response pathways (and this is the simple version!) Active RTK P P P P STAT PI3K PI3K PLCg SOS DAG InsP3 Rac PDK1 S6K Ras Cdc42 STAT~P PKC CaMK ROS PTP MAPK JNK PKB GSK3 Targets Targets Targets Targets Targets Apoptosis Targets Targets Targets Targets Targets Targets Nuclear Transcription Factors

  45. Growth Factors and Receptor Tyrosine Kinases • RTK’s--How do they work? • EGFR signaling and ras • MAP Kinase Cascades • PI3K, PKB, PLCg • PTPs (Protein Tyrosine Phosphatases)

  46. But how do you shut these things off? Family of Protein Phosphatases Tonks & Neel, Curr Op Cell Bio (2001)

  47. How Do PTPs dephosphorylate specific targets? Intracellular targeting: “zip code” model Extra domains on PTPs confer localization and protein-protein interactions Initially thought that catalytic domains possessed little specificity for RTKs. However, co-crystal structures and biochemistry reveal that some PTPs catalytic domains exhibit exquisite sensitivity PTP-1B critical residuesinteract with Insulin Receptor T-loop residues Salmeen, et al Mol Cell (2000)

  48. PTEN opposes PI3K by removing PI3-phosphate PTEN discovered as a tumor suppressor gene. Mutated in brain, breast and prostate cancers. Has homology to dual specificity phosphates, but shows little activity toward phosphoproteins. Was discovered to remove phosphates from PIPs; thereby providing likely mechanism for tumor suppression. Cantley & Neel, PNAS (1999)

  49. Gleevec--proof that you can target kinases for drug therapy Goldman & Melo, NEJM, Oct 9, 2003

  50. Gleevec--proof that you can target kinases for drug therapy

More Related